Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urticaria and Angioedema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04414631
What this trial is testing

Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Who this might be right for
Coronavirus Infections
University Hospital, Basel, Switzerland 80
Not applicableStudy completedNCT06096077
What this trial is testing

Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department

Who this might be right for
Angioedema
Methodist Health System 50
Not applicableUnknownNCT00163839
What this trial is testing

The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema

Who this might be right for
UrticariaAngioedema
Bayside Health 50
Testing effectiveness (Phase 2)WithdrawnNCT01832896
What this trial is testing

Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema Types I and II
NYU Langone Health
Early research (Phase 1)Study completedNCT02125162
What this trial is testing

The Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161

Who this might be right for
Hereditary Angioedema
BioCryst Pharmaceuticals 28
Large-scale testing (Phase 3)Study completedNCT00262080
What this trial is testing

Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 91
Testing effectiveness (Phase 2)Ended earlyNCT05055258
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II

Who this might be right for
Angioedema, Hereditary, Types I and II
KalVista Pharmaceuticals, Ltd. 33
Post-approval studies (Phase 4)Looking for participantsNCT07654829
What this trial is testing

Safety and Effectiveness of Sebetralstat (KVD900) for Short-Term Prophylaxis Before Procedures in People With Hereditary Angioedema (KONTROL)

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 100
Early research (Phase 1)Study completedNCT04557319
What this trial is testing

Safety and Pharmacokinetics of GNR-038 in Healthy Volunteers

Who this might be right for
Hereditary Angioedema
AO GENERIUM 36
Large-scale testing (Phase 3)Study completedNCT04656418
What this trial is testing

CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks

Who this might be right for
Hereditary Angioedema
CSL Behring 64
Early research (Phase 1)Study completedNCT02448264
What this trial is testing

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Western and Japanese Volunteers

Who this might be right for
Hereditary Angioedema
BioCryst Pharmaceuticals 122
Large-scale testing (Phase 3)Looking for participantsNCT06960213
What this trial is testing

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

Who this might be right for
Hereditary AngioedemaHAEHereditary Angioedema - Type 1+1 more
ADARx Pharmaceuticals, Inc. 90
Not applicableLooking for participantsNCT06573723
What this trial is testing

Institutional Registry of Rare Diseases

Who this might be right for
Rare DiseasesAmyloidosisSarcoidosis+23 more
Hospital Italiano de Buenos Aires 380
Large-scale testing (Phase 3)WithdrawnNCT01253382
What this trial is testing

Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire
Large-scale testing (Phase 3)Study completedNCT00997204
What this trial is testing

EASSI - Evaluation of the Safety of Self-Administration With Icatibant

Who this might be right for
Hereditary Angioedema
Shire 151
Post-approval studies (Phase 4)Study completedNCT07290855
What this trial is testing

Evaluate the Safety and Efficacy of Icatibant in Patients With Bradykinin Induced Angioedema

Who this might be right for
Bradykinin-mediated AngioedemaHereditary Angioedema (HAE)
Nang Kuang Pharmaceutical Co., Ltd. 5
Testing effectiveness (Phase 2)Study completedNCT05695248
What this trial is testing

Navenibart (STAR-0215) in Participants With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Astria Therapeutics, Inc. 29
Large-scale testing (Phase 3)Looking for participantsNCT07298447
What this trial is testing

Donidalorsen Treatment in Children With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Ionis Pharmaceuticals, Inc. 20
Not applicableLooking for participantsNCT03845946
What this trial is testing

CLOUD-R HAE REGISTRY

Who this might be right for
ANGIOEDEMA
University Hospital, Grenoble 1,000
Not applicableStudy completedNCT03240991
What this trial is testing

Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)

Who this might be right for
Angioedema
Centre Hospitalier Universitaire de Besancon 45
Next Page